Surgical

MetaMatrix Antibacterial Surgical Collagen

Pioneering Innovation in Surgical Collagen

‍

MetaMatrix Collagen Dressing is an advanced wound care device derived from 100% bovine Type I collagen.MetaMatrix Collagen is a biodegradable pad to absorb exudate. Based on in vitro performance data, MetaMatrixSurgical Collagen exhibits broad spectrum antibacterial activity due to its low pH. Antimicrobial EffectivenessTesting  demonstrates a >4 log reduction in all test organisms from 24 hours to 28 days.

Product Sizes

If you do not see a size that you require, please contact us by calling (972) 893-4090

4" x 4" Border w/ 2.4" x 2.4" Pad | 1 box | Quantity: 10
4" x 4" Border w/ 2.4" x 2.4" Pad | 1 box | Quantity: 10

Product Sizes

MeatMatrix Sheets

MP00384 - MetaMatrix Surgical Collagen Dressing 8” x 12” (1/box; 10 boxes/case)
MP00385 - MetaMatrix Surgical Collagen Dressing 1” x 1” (1/box; 50 boxes/case)
MP00386 - MetaMatrix Surgical Collagen Dressing 2” x 2” (1/box; 50 boxes/case)
MP00387 - MetaMatrix Surgical Collagen Dressing 3” x 3” (1/box; 10 boxes/case)
MP00388 - MetaMatrix Surgical Collagen Dressing 4” x 5” (1/box; 10 boxes/case)
MP00389 - MetaMatrix Surgical Collagen Dressing 7” x 7” (1/box; 10 boxes/case)

MetaMatrix Powder

META10 - MetaMatrix Surgical Collagen Powder 2.5 mL (12 boxes/Case)
META20 - MetaMatrix Surgical Collagen Powder 5 mL (12 boxes/case)
MP00383 - MetaMatrix 1 Gram Vial (5/box; 10 boxes/case)

If you do not see a size that you require, please contact us by calling (972) 893-4090.

MetaMatrix Applications

  • Partial and full thickness wounds
  • Pressure (stage I IV) and venous ulcers
  • Ulcers caused by mixed vascular etiologie
  • Venous stasis and diabetic ulcers
  • 1st and 2nd degree burns
  • Cuts, abrasions and surgical wounds
  • Full thickness surgical wounds

‍

MetaMatrix Data

Based on USP criteria, Bacteria is not less than 2.0 log reduction from the initial count at 14 days, and no increase from the 14 days' count at 28 days. Yeast and Molds has no increase from the initial calculated count at 14 and 28 days. This study was anR&D rapid efficacy test and shows the immediate reduction necessary to extrapolate across 28 days. Biochroma Analytical labs, LLC recommends a full28-day study once product goes into production. Currently, this sample passes the preservative efficacy examination.

Indications for Use

This product may be used in the management of partial and full thickness wounds, venous stasis and diabetic ulcers, pressure (stage I IV) and venous ulcers, 1s & 2nd degree burns, ulcers caused by mixed vascular etiologies, cuts, abrasions and surgical wounds, and full thickness surgical wounds.

Clinical Resources

Brochure

Still have questions? Start a Converstion!

Contact Us